SILVERTHORNE, CO, August 24, 2010 Keystone Symposia on Molecular and Cellular Biology will convene its conference on "Immunological Mechanisms of Vaccination" in Seattle, Washington from October 27 to November 1, 2010 at Sheraton Seattle Hotel. This is the first conference of Keystone Symposia's 40th meeting season and its first in Seattle. It will be held at the conclusion of the Grand Challenges in Global Health conference, also taking place in Seattle for that program's grant recipients earlier in the week.
Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation, the meeting will begin with keynote addresses on the evening of October 27, 2010 by Anthony S. Fauci of NIH and Tadataka Yamada of Bill & Melinda Gates Foundation, as well as a joint reception with the Grand Challenges in Global Health conference attendees.
Additional speakers over the course of the following four days will include Rafi Ahmed of Emory University School of Medicine, Norman Baylor of the US FDA, Robert L. Coffman of Dynavax Technologies, Stefan H.E. Kaufmann of Max Planck Institute for Infection Biology, Lalita Ramakrishnan of the University of Washington and many others. Concluding remarks on the evening of October 31 will be delivered by Peter C. Doherty of the University of Melbourne, one of two 1996 winners of the Nobel Prize in Medicine or Physiology for discovering how white blood cells recognize and kill virus-infected cells.
The four-day conference will bring together more than 400 researchers from around the world confronting a range of different diseases that would benefit from vaccine development. Included among the attendees will be 58 researchers and students originating from 27 developing countries who have received Keystone Symposia Global Health Travel Awards to attend the conference.
The goal of the meeting is to bring together, and encourage crosstalk between, vaccinologists, immunolo
|Contact: Yvonne Psaila|
Keystone Symposia on Molecular & Cellular Biology